First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study

Siow Ming Lee, Christian Klaus Jochen Schulz, Kumar Prabhash et al. · The Lancet · 2023

Cited by 167 works. doi:10.1016/s0140-6736(23)00774-2

Authors

References